Pharma

A Down Under infrastructure acquisition from Brookfield Asset Management valued at over $1 billion topped the private market transactions we tracked today.

Summer started out with a bang as private market players ponied up liberally across a wide variety of asset classes and sectors, including cloud, software, life sciences and the energy transition.

Our second daily edition of AW Deal Watch clocked in just shy of $1 billion in disclosed private market deals across private equity, credit, infrastructure and digital assets.

An affiliate of H.I.G. Capital acquired Aspire Pharma Limited, a U.K. provider of niche generic and branded specialty pharmaceuticals, in partnership with Aspire Founder Graham Fraser-Pye. Terms of the transaction were not disclosed. Founded in 2009, Aspire has a diversified ...